Nicholas Van Niel
Education
M.B.A., MIT Sloan School of Management; B.A., economics, Colby College
Summary of Experience
Mr. Van Niel consults on matters involving complex quantitative analyses, primarily in the health care sector, addressing litigation, regulatory, strategy, and policy questions. He has extensive experience applying advanced economic, statistical, and AI-enabled methods to large datasets of health care transactions, insurance claims, and public-health information to analyze health outcomes, pricing, contracting, distribution, and supply-chain practices, as well as consumer behavior and market responses. Mr. Van Niel works closely with academic and industry experts across disciplines, including medicine, epidemiology, health policy, and economics, to support expert testimony and client engagements in complex and evolving regulatory environments.
Mr. Van Niel regularly supports pharmaceutical manufacturers, distributors, and pharmacy chains in controlled substances matters, including the development and implementation of suspicious order monitoring tools, loss-prevention algorithms, and ordering- and dispensing-level analytics. He regularly presents analytical findings to corporate executives and government officials, including representatives from the Drug Enforcement Administration (DEA), US Attorneys’ Offices, and state attorneys general offices.